United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jul 7, 2026 · Filed Jul 8, 2026

On Jul 7, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$558.87 for US$5.31M under a trading plan, leaving 40,513 shares. Filed Jul 8, 2026 (Form 4).

Sold
9,500 shares
Price
US$558.87 average (US$553.12 to US$563.24)
Value
US$5.31M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 7, 2026Common StockOption exercise9,500US$135.4250,013Direct
Jul 7, 2026Common StockSale200US$553.1249,813Direct
Jul 7, 2026Common StockSale241US$554.3649,572Direct
Jul 7, 2026Common StockSale596US$555.5048,976Direct
Jul 7, 2026Common StockSale726US$556.5548,250Direct
Jul 7, 2026Common StockSale1,096US$557.7847,154Direct
Jul 7, 2026Common StockSale1,875US$558.9045,279Direct
Jul 7, 2026Common StockSale3,399US$559.7641,880Direct
Jul 7, 2026Common StockSale505US$560.4941,375Direct
Jul 7, 2026Common StockSale800US$562.6040,575Direct
Jul 7, 2026Common StockSale62US$563.2440,513Direct

Source

View original at SEC

Related